DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

8296	Companies
114899	Keywords
55318	Articles
62453	Press releases

Home
Companies
DBV TECHNOLOGIES

BRIEF

published on 10/22/2024 at 22:50, 29 days 14 hours ago

Le patch Viaskin Peanut de DBV obtient des avancées réglementaires aux États-Unis et dans l'UE

Approbation De La FDA DBV Technologies Viaskin Peanut Mise À Jour Réglementaire Orientations De L'EMA
PRESS RELEASE

published on 10/22/2024 at 22:45, 29 days 14 hours ago

DBV annonce des avancées règlementaires positives pour le patch Viaskin® Peanut aux États-Unis et en Europe
DBV Technologies annonce des avancées règlementaires pour le patch Viaskin® Peanut aux États-Unis et en Europe, incluant une procédure d'approbation accélérée aux Etats-Unis pour les enfants de 1 à 3 ans

FDA DBV Technologies Enfants Viaskin Peanut Procédure D'approbation Accélérée
PRESS RELEASE

published on 10/22/2024 at 22:45, 29 days 14 hours ago

DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
DBV Technologies announces positive regulatory updates for Viaskin Peanut Patch in the United States and Europe, aiming for Accelerated Approval for toddlers 1-3 years old

Accelerated Approval Regulatory Updates DBV Technologies Viaskin Peanut Patch Toddlers
BRIEF

published on 10/18/2024 at 22:35, 1 month 2 days ago

DBV Technologies participera au congrès ACAAI 2024

DBV Technologies Traitement Des Allergies ACAAI 2024 Allergie Aux Arachides Patch À L'arachide Viaskin
BRIEF

published on 10/18/2024 at 22:35, 1 month 2 days ago

DBV Technologies to Engage in ACAAI 2024 Congress

DBV Technologies Allergy Treatment Peanut Allergy Viaskin Peanut Patch ACAAI 2024
PRESS RELEASE

published on 10/18/2024 at 22:30, 1 month 2 days ago

DBV Technologies participera au prochain congrès de l'ACAAI 2024
DBV Technologies participera au congrès annuel de l'ACAAI à Boston pour discuter du traitement de l'allergie à l'arachide avec son patch Viaskin®. Détails sur les intervenants et les sessions

DBV Technologies Congrès ACAAI Allergie À L'arachide Viaskin® Peanut
PRESS RELEASE

published on 10/18/2024 at 22:30, 1 month 2 days ago

DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
DBV Technologies to participate in ACAAI 2024 Congress, presenting on optimal peanut allergy treatment and sponsoring FIT Bowl. Viaskin Peanut patch for food allergies highlighted

DBV Technologies Food Allergies Viaskin Peanut Patch ACAAI 2024 Congress Peanut Allergy Treatment
BRIEF

published on 10/14/2024 at 22:35, 1 month 6 days ago

DBV Technologies Share Capital Status as of September 30, 2024

Share Capital Voting Rights DBV Technologies Euronext Exchanges Listed Shares
BRIEF

published on 10/14/2024 at 22:35, 1 month 6 days ago

État du Capital Social de DBV Technologies au 30 Septembre 2024

Droits De Vote Capital Social DBV Technologies Échanges Euronext Actions Cotées
PRESS RELEASE

published on 10/14/2024 at 22:30, 1 month 6 days ago

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024
Total des droits de vote et d'actions du capital social au 30 septembre 2024 pour NYSE Euronext Paris selon l'Autorité des Marchés Financiers

Autorité Des Marchés Financiers Droits De Vote Capital Social Actions NYSE Euronext Paris

Accesswire

Published on 11/21/2024 at 13:00, 14 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 14 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 14 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 14 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 14 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 39 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 59 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 8 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 14 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 44 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 16 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 16 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 16 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 7 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 54 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE